Determination of persistent heart rhythm disorders predictors in military combatants with severe myocarditis

Main Article Content

E. G. Nesukay
V. M. Kovalenko
S. V. Cherniuk
O. I. Frolov
R. M. Kirichenko
A. B. Slyvna

Abstract

The aim – to study heart rhythm and conduction disturbances in different localization and distribution of myocardial lesions in combatants with severe myocarditis based on the results of a 6-month follow-up.
Materials and methods. 46 male military personnel with a severe course of acute myocarditis (AM) with a reduced ejection fraction (EF) of the left ventricle (LV) (≤ 40 %) with an average age of (35,1±2,4) years were examined. Examinations were carried out in the 1st month after the onset of symptoms of myocarditis and after 6 months of observation. The diagnosis of myocarditis and the severe course of the disease were established on the basis of the Recommendations for the diagnosis and treatment of myocarditis of the All-Ukrainian Association of Cardiologists of Ukraine. All patients underwent for 24-hour ECG monitoring with analysis of the frequency and spectrum of rhythm and conduction disturbances and cardiac magnetic resonance (CMR) imaging with contrast analysis of the topography of the lesion and counting the number of LV segments affected by inflammatory changes and LV segments with the presence of late gadolinium enhancement (LGE).
Results and discussion. When comparing the results of heart MRI with the data of daily ECG monitoring, a clear association of the presence of frequent ventricular extrasystoles (VE) and paroxysms of non-sustained ventricular tachycardia (NSVT) with the localization of LGE in the interventricular septum (IS) was established – among patients with LGE lesions at the onset of AM more than in a third (37.0 %) had frequent VE, and NSVT paroxysms, which increase the risk of developing life-threatening ventricular arrhythmias, were detected in 25,9 % of cases. After 6 months of observation in the presence of LGE in the IS, the frequency of detection of frequent VE and NSVT paroxysms was also significantly higher compared to other localization of the lesion and amounted to 20,0 and 13,3 %, respectively. With the help of correlation analysis, an associative relationship was revealed between the presence of LGE in the IS and the presence of frequent VE and NSVT paroxysms in the debut of myocarditis – r=0.73 (р<0.01) and r=0.66 (р<0,01) respectively, and also after 6 months of observation – r=0.65 (р<0.01) and r=0.59 (р<0.05), respectively. According to the results of the multivariate regression analysis, predictors of frequent VE persistence after 6 months were: LVEF ≤30 %; LV end-diastolic volume index ≥105 ml/m2; presence of inflammatory changes in ≥5.0 LV segments; presence of LGE in ≥4.0 LV segments and its presence in the IS, determined in the 1st month from the onset of the disease. The predictors NSVT paroxysms persistence after 6 months were the same factors with the exception of LV EF, and, according to the value of the β coefficient (β=1.302; p<0.001), the most significant contribution was the presence of LGE in the IS.
Conclusions. In combatants with severe myocarditis, the presence of late gadolinium enhancement in the interventricular septum is an additional risk factor for the persistence of frequent ventricular extrasystoles and paroxysms of non-sustained ventricular tachycardia during 6 months, while the presence of late gadolinium enhancement in the posterior and lateral walls of the left ventricle has no reliable relationship with the presence of rhythm and conduction disorders. On the basis of multivariate regression analysis, predictors of frequent ventricular extrasystoles and paroxysms of non-sustained ventricular tachycardia persistence were established in combatants with myocarditis.

Article Details

Keywords:

myocarditis, combatants, predictors, ventricular arrhythmias, late gadolinium enhancement, cardiac magnetic resonance

References

Kovalenko VM, Lutai MI, Sirenko YuM, Sychov OS. Sertsevo-sudynni zakhvoriuvannia: klasyfikatsiia, standarty diahnosty­­ky ta likuvannia. 6-te vydania. Kyiv: Chetverta khvylia, 2023. 384 s. ISBN 978-966-529-358-3. Ukrainian.

Kovalenko VM, Nesukay EG, Cherniuk SV, Kozliuk AS, Kirichenko RM. Diagnosis and Treatment of Myocarditis. Ukr J Cardiol. Sept. 2021;28(3):67-88. Ukrainian. https://doi.org/10.31928/1608-635X-2021.3.6788.

Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, Deal BJ, Dickfeld T, Field ME, Fonarow GC, Gillis AM, Granger CB, Hammill SC, Hlatky MA, Joglar JA, Kay GN, Matlock DD, Myerburg RJ, Page RL. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task force on clinical practice guidelines and the heart rhythm society. Circulation. 2018; 138:e272-e391. https://doi.org/10.1161/CIR.0000000000000549.

Ammirati E, Frigerio M, Adler ED, Basso C, Birnie DH, Brambatti M, Friedrich MG, Klingel K, Lehtonen J, Moslehi JJ, Pedrotti P, Rimoldi OE, Schultheiss HP, Tschöpe C, Cooper LT Jr, Camici PG. Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy. Circ. Heart Fail. 2020; 13:e007405. doi: 10.1161/CIRCHEARTFAILURE.120.007405.

Brociek E, Tymi´nska A, Giordani AS, Caforio AL, Wojnicz R, Grabowski M, Oziera´nski K. Myocarditis: Etiology, Pathogenesis, and Their Implications in Clinical Practice. Biology. 2023; 12:874. https://doi.org/10.3390/ biology12060874.

Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, Fu M, Heliö T, Heymans S, Jahns R, Klingel K, Linhart A, Maisch B, McKenna W, Mogensen J, Pinto YM, Ristic A, Schultheiss HP, Seggewiss H, Tavazzi L, Thiene G, Yilmaz A, Charron P, Elliott PM; European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Current state of knowledge on aetiology, diagnosis, management and therapy of myocarditis: a position statement of the ESC Working group on myocardial and pericardial diseases. Eur Heart J. 2013; 34(33):2636-2648, https://doi.org/10.1093/eurheartj/eht210.

Ferreira VM, Schulz-Menger J, Holmvang G, Kramer CM, Carbone I, Sechtem U, Kindermann I, Gutberlet M, Cooper LT, Liu P, Friedrich MG.Cardiovascular magnetic resonance in nonischemic myocardial inflammation: Expert recommendations. J. Am. Coll. Cardiol. 2018; 72(24):3158-76. https://doi.org/10.1016/j.jacc.2018.09.072.

Gräni C, Eichhorn C, Bière L, Murthy VL, Agarwal V, Kaneko K, Cuddy S, Aghayev A, Steigner M, Blankstein R, Jerosch-Herold M, Kwong RY. Prognostic value of cardiac magnetic resonance tissue characterization in risk stratifying patients with suspected myocarditis. JACC. 2017; 70(16):1964-76. https://doi.org/10.1016/j.jacc.2017.08.050.

Hundley WG, Bluemke DA, Finn JP, Flamm SD, Fogel MA, Friedrich MG, Ho VB, Jerosch-Herold M, Kramer CM, Manning WJ, Patel M, Pohost GM, Stillman AE, White RD, Woodard PK. ACCF/ACR/AHA/NASCI/SCMR 2010 Expert consensus document on cardiovascular magnetic resonance: a report of the American college of cardiology foundation task force on the expert consensus documents. J Am Coll Cardiol. 2010; 55(23):2614-62. https://doi.org/10.1161/CIR.0b013e3181d44a8f.

Hutt E, Kaur S, Jaber WA. Modern tools in cardiac imaging to assess myocardial inflammation and infection. Eur Heart J Open. 2023;3(2):oead019. https://doi.org/10.1093/ehjopen/oead019.

Jiang L, Zuo H, Liu J, Wang J, Zhang K, Zhang C, Peng X, Liu Y, Wang D, Li H, Wang H.The pattern of late gadolinium enhancement by cardiac MRI in fulminant myocarditis and its prognostic implication: A two-year follow-up study. Frontiers in Cardiovascular Medicine. 2023;10:1144469. https://doi.org/10.3389/fcvm.2023.1144469.

Kuruvilla S, Adenaw N, Katwal AB, Lipinski MJ, Kramer CM, Salerno M. Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: a systematic review and meta-analysis. Circulation: Cardiovascular Imaging. 2014; 7(2):250-8. https://doi.org/10.1161/CIRCIMAGING.113.001144.

Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU.Recommendations for cardiac chamber quantification in adults: an update from the American Society of echocardiography and European Asssociation of cardiovascular imaging. J Am Soc Echocardiogr. 2015;28(1):1-38. https://doi.org/10.1016/j.echo.2014.10.003.

Lynge TH, Nielsen TS, Gregers Winkel B, Tfelt-Hansen J, Banner J. Sudden cardiac death caused by myocarditis in persons aged 1-49 years: a nationwide study of 14 294 deaths in Denmark. Forensic Sciences Research. 2019; 4:247-256. https://doi.org/10.1080/20961790.2019.159535.

Mahrholdt H, Greulich S. Prognosis in myocarditis: better late than (n) ever! J Amer Coll Cardiol. 2017;70(16):1988-90. https://doi.org/10.1016/j.jacc.2017.08.062.

McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal. 2021; 42(36):3599-3726. https://doi.org/10.1093/eurheartj/ehab368.

Peretto G, Sala S, Rizzo S, De Luca G, Campochiaro C, Sartorelli S, Benedetti G, Palmisano A, Esposito A, Tresoldi M, Thiene G, Basso C, Della Bella P. Arrhythmias in myocarditis: state of the art. Heart rhythm. 2019; 16(5):793-801. https://doi.org/10.1016/j.hrthm.2018.11.024.

Peretto G, Sala S, Rizzo S, Palmisano A, Esposito A, De Cobelli F, Campochiaro C, De Luca G, Foppoli L, Dagna L, Thiene G, Basso C, Della Bella P.Ventricular arrhythmias in myocarditis: characterization and relationships with myocardial inflammation. Journal of the American College of Cardiology, 2020; 75(9):1046-1057. https://doi.org/10.1016/j.jacc.2020.01.036.

Polte CL, Bobbio E, Bollano E, Bergh N, Polte C, Himmelman J, Lagerstrand KM, Gao SA. Cardiovascular Magnetic Resonance in Myocarditis. Diagnostics. 2022;12:399. https://doi.org/10.3390/diagnostics12020399.

Tschöpe C, Ammirati E, Bozkurt B, Caforio ALP, Cooper LT, Felix SB, Hare JM, Heidecker B, Heymans S, Hübner N, Kelle S, Klingel K, Maatz H, Parwani AS, Spillmann F, Starling RC, Tsutsui H, Seferovic P, Van Linthout S. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nat Rev Cardiol. 2021;18(3):169-93. https://doi.org/10.1038/s41569-020-00435-x.

Younis A, Matetzky S, Mulla W, Masalha E, Afel Y, Chernomordik F, Fardman A, Goitein O, Ben-Zekry S, Peled Y, Grupper A, Beigel R. Epidemiology characteristics and outcome of patients with clinically diagnosed acute myocarditis. American Journal of Medicine. 2020; 133:492-499. https://doi.org/10.1016/j.amjmed.2019.10.015.

Most read articles by the same author(s)

1 2 > >>